IP Offerings Logo

Patent MarketPlace: Medical Device Patents for Sale

Non-Radiation/Non-Chemotherapy Cancer Treatment (Elbe): International Patent Portfolio

Laying siege to a city and starving its citizens into surrender has been an effective military strategy for centuries. The Romans laid siege to Tyre in 332 BC, and the Germans laid siege to Leningrad in 1941 AD. The enemy surrounds a city, cuts it off the from the outside world, and starves its residents into submission and surrender. It is an effective, but brutal, strategy. This portfolio takes a similar approach to a brutal enemy – cancer. This international patent portfolio covers technology for selectively cutting off red blood cell flow to a tumor, starving the tumor of the nutrition it needs to survive and grow. The result is that the cancer is significantly slowed down – i.e., goes into remission – or it dies from lack of nutrition. Micro devices are injected into blood vessel(s) upstream of the tumor, and they occlude blood flow as directed by processors.

This portfolio creates a comprehensive cancer treatment that also includes a self-correcting RFI system that enables microbots to measure their position in a human body with micron-level precision while correcting in real-time for signal aberrations as the radio waves pass through the body. Additionally, a 3D ultrasonic imaging system provides high-contrast imaging via a digital synthetic aperture. This is an entirely new approach to medical imaging that eliminates the need for exposing patients to ionising radiation and allows a patient to move around freely during a scan.

Patent Portfolio

This portfolio will enable a medical device manufacturer to bring to market a highly effective cancer treatment technology that avoids the unfortunate side effects of radiation and chemotherapy.

Infection-Prevention Bandage-Swab Kit (Khan): U.S. Patent No. 8,240,472

The biggest single risk in treating a wound is infection. Everything that comes in touch with the wound has to be 100% sterile, and that is not always easy nor practical. When a treatment has to be applied to the wound, it is often done with a swab. The problem often is that the swab comes in touch with different surfaces and objects on its way from its sterile packaging to the wound. And that creates a source of infection. Not good.

This patent tackles that issue head-on, and – like so many patents – the invention is brilliantly simple. Both a sterile bandage and a sterile swab are packaged together in a two-compartment sealed kit. The sterile swab is removed from its sterile compartment and immediately used to apply treatment to the wound before it can touch any foreign object or it comes in contact with any surfaces. Then the sterile bandage is removed from the second sterile compartment and applied to the wound. So, both the swab and the bandage remain 100% sterile, significantly reducing the risk of infection. The container holding the swab and bandage can also contain an antibacterial agent, so the swab and bandage are ready-to-use. Quick and proper attention to a wound will speed healing and reduce scarring.

U.S. Patent No. 8,240,472 for a “Combination bandage and wound treatment system” would enable any supplier of medical products to offer an affordable, practical, and totally sterile would-care solution! It can be offered as an over-the-counter product for consumers, a product for medical professionals at hospitals and other medical facilities, a wound-treatment kit to take camping, fishing, or hunting, or as a component in first-aid kits.

Blood Clot Prevention Device (Khan): U.S. Patent No. 8,579,841

Blood clotting or coagulation is an important human process that enables blood to dry and form a protective covering over wounds. However, when blood clots form in the arteries – known as thrombosis – it becomes a serious health hazard. When clots collect in the deep veins in the legs or arms – a condition known as venous thromboembolism or deep vein thrombosis (DVT) – those clots can make their way to the heart, lungs, or brain and result in a stroke or death. As the U.S. population ages, deep vein thrombosis will become an increasingly more serious medical condition.

This patent covers a pressure cuff that contains bladders that are arranged in succession down the arm or leg of a user. An air compressor inflates the bladders, and a control module sequentially opens valves in the bladders to provide pressure in succession along the arm or leg of the patient. Additionally, tubes equalize pressure between bladders before exhausting air from a previously pressurized bladder to allow for increased patterns of bladder pressure. Pressure levels and bladder dwell times may be adjusted by the user or his or her physician, or can be based on predetermined settings. The device can also provide electrical stimulation, pulsations, heating, and cooling to increase blood flow and totally eliminate – or substantially reduce – clotting in the limbs.

U.S. Patent No. 8,579,841 for a “Blood clot prevention device” can be used to create a highly effective, non-drug, no-side-effects treatment for blood clotting in the arms and legs. This patent would be a strategic acquisition for any medical product manufacturer.

Medication Dispenser (Mauk): U.S. Patent No. 7,584,849

As America ages, a larger and larger portion of the population needs to take one or more prescription drugs on a regular basis. In fact, 85% of Americans over 60 take at least one prescription drug once a day. In addition to this, many younger, healthier Americans take vitamins and supplements on a regular basis. The challenge for both groups is keeping track of what drug or vitamin or supplement has and has not been taken each day.

This patent creates a tool for those who take drugs, vitamins, and/or supplements to make sure that no dosage is missed and the user does not double-dose. The device has adjustable slots that hold the bottles of medications, vitamins, or supplements, and a grid of pill dispensers, four (Morning, Noon, Evening, and Bedtime) for each day of the week for a total of 28. The user or caregiver fills each dispenser slot once a week with the pills or capsules to be taken at each time of the day. The unit includes an electronic display that shows what time of day it is. If a dispenser slot is empty, that means the user took those pills. If there are still pills in the slot, he or she forgot, and needs to take them. It also includes a slide-out drawer that holds a record of the patient’s prescriptions and dosages.

This invention insures that the user takes the medicines prescribed for him or her, along with the vitamins and supplements the user is taking, as prescribed. It eliminates the user – often an older person with diminished mental acuity – from both forgetting to take his or her medicine and accidentally double-dosing. U.S. Patent No. 7,584,849 for a “Home medication station” would enable a supplier of healthcare products to offer a highly useful product that purchasers will use and appreciate.

Specialized Skin Exfoliation (Perez): U.S. Patent No. 8,585,621

The skin is the largest organ in the human body. The outer layer of skin is continually dying and being replaced by new skin that replaces it. When a person gets a tan, that tan is a layer of darker, dead skin. Elbows, however, create a special problem. Dead skin builds up on the elbows, causing them to get darker and darker, creating a condition known as “Dark Elbows.” While Dark Elbows are not a health hazard, they can be very unattractive. This patent creates a device that specifically addresses Dark Elbows and other specialized skin exfoliation needs.

This patent creates a tabletop or floor-based skin exfoliation device that is enclosed in a housing. The user turns it on and places his or her elbows on the top surface of the device. The vibrating abrasive surface gently cleans away the dead skin from the elbows, eliminating Dark Elbows, and leaving a consistent skin tone on the user’s arms. The unit can also be placed on the floor, and the user can place his or her feet on the device to remove dead skin from the heels and soles of the feet. For the treatment of Dark Elbows, and for exfoliating feet, this device is clearly superior to the current generation of handheld exfoliation devices that are on the market.

U.S. Patent No. 8,585,621 for a “Skin exfoliation apparatus” would be a strategic acquisition for any manufacturer of exfoliation products looking to expand its product offerings, or for any medical device manufacturer seeking to expand into the huge exfoliation market with a unique, patent-protected product.

Laminitis Treatment for Horses (Medergo): U.S. Patent No. 8,465,444 and European Patent Application

Horses are smart, affectionate, and incredibly loyal. It is a shame that hundreds of horses a year have to be euthanized because they suffer from laminitis - an inflammation of the soft tissue structures that attach the coffin or pedal bone of the foot to the hoof wall known as “laminae” – and they cannot be effectively treated. As laminitis (also known as “founder”) progresses, a horse can eventually not stand or walk, and the horse must be put down. Such a tragedy for such wonderful animals that have been bred and raised and cared for by humankind for centuries.

This portfolio creates an effective and affordable treatment for laminitis. The invention is a garment wrap that is secured to the animal's leg and includes inflatable chambers that engage critical points on the horse’s leg and hoof. The inflatable chambers are pressurized in a sequence that prevents backflow from a more proximal point on the animal's leg to a more distal point on the leg. A boot with an inner sole pad is also used during the therapy procedure and afterwards, and the inner sole pad can be used to administer medications as well as for an iontophoresis procedure. The boot assists with other treatments to increase circulation to aid healing in the hoof by increasing blood flow.

Wounds and problems of the legs of horses are the result of poor circulation along with lymphedema, venous stasis, trauma, cellulitis, and postsurgical swelling. In addition to treatment of laminitis, this invention can be used as a rehabilitative device as well as a conditioning tool for animals that are recuperating from other conditions. This treatment for horses was developed from a similar method used with great success on thousands of human patients with circulatory issues.

This portfolio includes U.S. Patent No. 8,465,444 and European Patent Application 2983634 for “Laminitis treatment system and method.” The acquirer of this portfolio can create the first effective and affordable – as well as life-saving – treatment for laminitis in hoofed animals with patent protection on two continents.

Next-Generation Electrotherapy (Li): U.S. Patent No. 10,471,253

The earth is a huge magnet with a positive and negative pole. All animals on the earth carry that same positive and negative magnetic charge, including all humans. Electrotherapy – the application of low-voltage electric current through the human body – has been proven to treat many conditions, from relieving pain to healing wounds, by improving the electromagnetic balance in the body. Also known as electromagnetic therapy, the treatment of diseases and afflictions via electrotherapy goes back over 200 years. The first recorded use of electrotherapy was by Johann Gottlob Krüger in 1743. John Wesley, an Anglican clergyman and the founder of the Methodist Church, was a proponent of electrotherapy.

This patent takes electrotherapy to the next level by creating a device for applying a carefully controlled and regulated flow of electrons to the human body in a field between positive and negative electrodes. It includes an electric field detector that measures and transmits data about the strength of the actual electric field back to the operator. A microprocessor receives this data and compares it against the parameters of a wellness-promoting electric field so the pulse-width modulator is operating at optimal performance. The wellness of a patient is enhanced by ensuring that the positive electrode is in correct approximation to a positive location on the patient and the negative electrode is in correct approximation to a negative location on the patient. A flow of electrons at the right strength has been documented to treat such maladies as depression, muscle pain, constipation, sinus infection, low blood pressure, nausea and vomiting, insomnia, infertility, asthma and tinnitus, to name just a few.

U.S. Patent No. 10,471,253 for a “System and method to modulate an electric field in an environment” would enable a medical device manufacturer to introduce a product for those seeking treatment of their disease or condition via a controlled electrical field.

Capsule that Diagnoses and Treats Intestinal Tract (Entrack): International Patent Portfolio

In Isaac Asimov’s “Fantastic Voyage,” a ship and a medical crew were shrunk to microscopic size to perform diagnosis and surgery from within the body. Asimov’s visions are realized in part in this portfolio. It provides broad coverage of an autonomous swallowable capsule that can pass through the gastrointestinal (GI) tract of a body to diagnosis and/or treat conditions in the GI tract. As it passes through the intestinal tract, the capsule can perform one or more diagnostic functions – detect the presence of blood or other abnormal tissue conditions, for example. It can also report its location and findings wirelessly. This allows for the development of a diagnostic map of the GI tract which can be used by a physician to pinpoint the location of an adverse condition such as a polyp in the colon. Additionally, the capsule can be programmed to deliver medication or other treatments to a selected tissue site or to mark the tissue site for later treatment. The capsule covered by this portfolio can reduce or totally eliminate the need to perform more costly invasive procedures such as colonoscopies and GI surgeries.

Patent No.Title
US 7,160,258Capsule and method for treating or diagnosing the intestinal tract
US 7,824,347System for marking a location for treatment within the gastrointestinal tract
US 8,005,536Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US 8,360,976Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US 8,517,961System for marking a location for treatment within the gastrointestinal tract
US 8,617,070Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US 8,915,867System for marking a location for treatment within the gastrointestinal tract
US 10,226,608Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract

This portfolio also includes Japanese Patent 2004548055 for a “Diagnostic capsule and method of using the same.” This is both a robust and a foundational patent portfolio. The U.S. Patents in the portfolio share a 2001 Priority Date, and each U.S. Patent has over 400 Forward Citations! This portfolio would be a strategic acquisition for any medical device manufacturer!

Bacteria Biosensor Detection System (Edmonson): Two U.S. Patents, Canadian Patent and Prototypes

When examining a patient, and a bacterial infection is suspected, it is important for the physician to know quickly if live bacteria are present. Farmers need to know if bacteria are present that can be a threat to their crops and feedstocks. Food processing plants need to be able to quickly detect if bacteria are present in food processing, handling and storage equipment and locations. The invention covered by this portfolio addresses exactly that need by creating a low-cost, portable, easy-to-use bacteria biosensor that can detect the presence of live bacteria in real time.

Patent No.Title
US 7,651,843Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
US 8,420,382Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
CA 2520812Method and system for archiving biomedical data generated by a data collection device

This portfolio covers an invention that detects, isolates and characterizes the QS signals made by both Gram Positive and Gram Negative bacteria. It creates a low-cost, small and portable testing unit for at-home, in-clinic, in-facility or in-field use. It can detect bacteria in either vapor or liquid, as a breathalyzer-type bacteria monitor, or a unit that can be placed in a location to sample the surrounding air for bacterial-signaling molecules.

In addition to the two U.S. Patents and the Canadian Patent, this portfolio includes working prototypes, so the company that acquires this property will be able to go to market very quickly with a bacteria biosensor that is cheaper than current products, produces results faster, and can be used in many more locations and applications!

ID/Medical Data/Alerts System (Solomon Systems): Five U.S. Patents

What happens when a person needs medical attention, but that person is unconscious? Or seriously injured or disabled? Or cannot speak? Or is disoriented and not totally lucid? It is difficult to provide medical care without at least some basic health information about that person. This challenge – an increasingly common occurrence – is what the invention covered by this portfolio addresses.

This portfolio covers a health-record provisioning system with multiple advantages:

The portfolio includes U.S. Patent Nos. 8,181,862, 8,485,439, 8,833,649, 9,165,335 and 9,390,231 titled "System for Providing Identification and Information, and for Scheduling Alerts." Included in the portfolio are two Chinese Patent Applications and a PCT Application. Technology covered by this portfolio has the capabilities to save lives, and it would give a critical competitive advantage to a healthcare provider, electronic device OEM or smartcard provider.

Ultrasound-Based Diagnostic Medical Imaging (Ramot University): Five U.S. Patents

This five-patent portfolio includes methods and systems to improve ultrasound-based diagnostic medical imaging. While ultrasounds have been used for over 50 years to image the human body and diagnose diseases. This portfolio discloses technology that advances the technology in several ways:

Patent No.Description
6,858,007Method and system for automatic classification and quantitative evaluation of adnexal masses based on a cross-sectional or projectional images of the adnex SOLD!
7,676,091Method and apparatus for analyzing ultrasound images

Logical acquirers of this technology include ultrasound imaging equipment OEMs, medical device and software providers, and medical research institutions.

Patent Brokerage Prospectus: Contact [email protected] to receive an analysis of each portfolio that includes:

We offer patents in these technologies: